ViewTube

Amer Zeidan, MBBS, MHS, Yale University and Yale Cancer Center, New Haven, CT, discusses the upcoming post-ASH webinar ...

Kerry Rogers, MD, Ohio State University, Columbus, OH, advocates for the continuous use of BTK inhibitors (BTKis) in chronic ...

Catherine Coombs, MD, UCI Health, Orange, CA, speaks on the evolving approach to frontline treatment for chronic lymphocytic ...

Shebli Atrash, MD, Levine Cancer Institute & Atrium Health, Charlotte, NC, discusses mechanisms of resistance to CAR T-cells in ...

Claudio Cerchione, MD, PhD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, ...

Krina Patel, MD, MSc, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the growing body of evidence ...

Yi Lin, MD, PhD, Mayo Clinic, Rochester, MN, comments on the measurable residual disease (MRD) negativity rates observed in ...

Welcome to the YouTube channel of the Video Journal of Hematology & Hematological Oncology. We are a global, open-access ...

Julio Chavez, MD, MS, Moffitt Cancer Center, Tampa, FL, presents the results from a multicenter study looking at patients 80 and ...

Monique Minnema, MD, PhD, University Medical Center Utrecht, Utrecht, Netherlands, highlights how immunotherapies, including ...

Inhye Ahn, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the limitations of continuous BTK inhibitor (BTKi) therapy for ...

Jonathan Friedberg, MD, MMSc, University of Rochester, Rochester, NY, discusses the results of the SWOG S1826 trial ...

Mark Litzow, MD, Mayo Clinic, Rochester, MN, discusses a study comparing the responses of acute lymphoblastic leukemia (ALL) ...

Barbara Eichhorst, MD, University Hospital Cologne, Cologne, Germany, highlights how the chronic lymphocytic leukemia (CLL) ...

Barbara Eichhorst, MD, University of Cologne, Cologne, Germany, discusses the EPCORE CLL-1 trial (NCT04623541), which ...

Catherine Coombs, MD, UCI Health, Orange, CA, underlines the factors physicians should consider when selecting patients with ...

Martina Seiffert, PhD, German Cancer Research Center, Heidelberg, Germany, discusses a study investigating the ...

Barbara Eichhorst, MD, University of Cologne, Cologne, Germany, shares details about the risk of infection in patients with chronic ...

Michael Wang, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the management of cardiac ...

Matthew Davids, MD, Dana-Farber Cancer Institute, Boston, MA, comments on the primary results of a multicenter, Phase II study ...